Clayco Completes Interior Build-out For Groundbreaking Pfizer-Washington University Research Collaborative
St. Louis, MO (July 8, 2010)
Clayco Inc. has recently completed interior tenant construction on a new office and laboratory project for CORTEX, the Center of Research, Technology and Entrepreneurial Expertise. The innovative space will house the groundbreaking collaboration between pharmaceutical manufacturer Pfizer Inc. and Washington University in St. Louis.
In an announcement made earlier this month, Pfizer revealed a five-year agreement to provide $22.5 million to Washington University and give its scientists access to research data on a large array of Pfizer pharmaceuticals that are currently or were formerly in clinical testing. The innovative partnership was established to encourage discovery of new uses for existing compounds.
Located in the CORTEX One Building on Forest Park Avenue, the construction project entails the build-out of unfinished tenant space. The 8,500-square-foot tenant finish space includes a large open office area with modular office seating, private offices, three large audio-visual equipped conference rooms and a state-of-the-art 600-square-foot research laboratory space.
“Clayco played a significant role in the creation and construction of the CORTEX One research and development building in 2006, and we are very pleased to be a part of yet another expansion of this innovative life sciences complex,” said Kirk Warden, Clayco Senior Vice President and Partner. “The environment created in the office and laboratory spaces embraces the shared goals of the academic and pharmaceutical researchers and will enhance their ability to make new discoveries and advancements.”
Clayco’s project team includes Warden, project director John Sabo, and project manager Beth Cerrone, working as a team with architect and interior designer Forum Studio.